Back to News
Market Impact: 0.2
Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities
Source: Newswire
M&A & RestructuringHealthcare & BiotechTechnology & Innovation
An acquisition adds PzF thin-film surface-modification technology, specialized expertise in blood- and tissue-contacting medical devices, and a West Coast testing facility. The transaction expands the acquirer's medical-device capabilities and testing infrastructure, though no financial terms or expected revenue impact were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Nvidia Faces Questions Over China AI Chip Smuggling Cases
- Broadcom to lend Anthropic up to $42 billion to lease its chips, filing says
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Nuveen CEO on Schroders Deal, Plans for Combined Company
- Paramount promised 30 movies a year to win Warner Bros. Losing Miramax if it fails may not scare it
- Markets slip on dollar pressure, but this IT stock is up 10% today